MOCTANIN Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Moctanin, and what generic alternatives are available?
Moctanin is a drug marketed by Ethitek and is included in one NDA.
The generic ingredient in MOCTANIN is monoctanoin. Additional details are available on the monoctanoin profile page.
Summary for MOCTANIN
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 95 |
Patent Applications: | 4,577 |
DailyMed Link: | MOCTANIN at DailyMed |
US Patents and Regulatory Information for MOCTANIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ethitek | MOCTANIN | monoctanoin | LIQUID;PERFUSION, BILIARY | 019368-001 | Oct 29, 1985 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for MOCTANIN
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Ethitek | MOCTANIN | monoctanoin | LIQUID;PERFUSION, BILIARY | 019368-001 | Oct 29, 1985 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |